These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25826157)

  • 1. Antibiotic dosing in obesity: the search for optimum dosing strategies.
    Tucker CE; Lockwood AM; Nguyen NH
    Clin Obes; 2014 Dec; 4(6):287-95. PubMed ID: 25826157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosing of antibiotics in obesity.
    Janson B; Thursky K
    Curr Opin Infect Dis; 2012 Dec; 25(6):634-49. PubMed ID: 23041773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic therapy of pneumonia in the obese patient: dosing and delivery.
    Al-Dorzi HM; Al Harbi SA; Arabi YM
    Curr Opin Infect Dis; 2014 Apr; 27(2):165-73. PubMed ID: 24504134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Guidance for Antibiotic Dosing in Obese Adults.
    Meng L; Mui E; Holubar MK; Deresinski SC
    Pharmacotherapy; 2017 Nov; 37(11):1415-1431. PubMed ID: 28869666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive literature review.
    Polso AK; Lassiter JL; Nagel JL
    J Clin Pharm Ther; 2014 Dec; 39(6):584-608. PubMed ID: 25203631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin Dosing in Obese Patients: Special Considerations and Novel Dosing Strategies.
    Durand C; Bylo M; Howard B; Belliveau P
    Ann Pharmacother; 2018 Jun; 52(6):580-590. PubMed ID: 29262697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjustment of dosing of antimicrobial agents for bodyweight in adults.
    Falagas ME; Karageorgopoulos DE
    Lancet; 2010 Jan; 375(9710):248-51. PubMed ID: 19875163
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of antibacterial agents in renal failure.
    Gilbert B; Robbins P; Livornese LL
    Infect Dis Clin North Am; 2009 Dec; 23(4):899-924, viii. PubMed ID: 19909890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of dosing regimens and dosing in special populations.
    Sime FB; Roberts MS; Roberts JA
    Clin Microbiol Infect; 2015 Oct; 21(10):886-93. PubMed ID: 25980350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Information provision for antibacterial dosing in the obese patient: a sizeable absence?
    Boyd SE; Charani E; Lyons T; Frost G; Holmes AH
    J Antimicrob Chemother; 2016 Dec; 71(12):3588-3592. PubMed ID: 27538956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of antibiotics in obese and critical care patients].
    Stahlmann R; Lode H
    Dtsch Med Wochenschr; 2015 Feb; 140(4):271-6. PubMed ID: 25704524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of obesity on antibiotic treatment failure: a historical cohort study.
    Longo C; Bartlett G; Macgibbon B; Mayo N; Rosenberg E; Nadeau L; Daskalopoulou SS
    Pharmacoepidemiol Drug Saf; 2013 Sep; 22(9):970-6. PubMed ID: 23733599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosing of antibacterial agents in obese adults: does one size fit all?
    Payne KD; Hall RG
    Expert Rev Anti Infect Ther; 2014 Jul; 12(7):829-54. PubMed ID: 24809811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of bacterial infections in obese adult patients: how to appropriately manage antimicrobial dosage.
    Pai MP
    Curr Opin Pharmacol; 2015 Oct; 24():12-7. PubMed ID: 26119488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility.
    Roberts JA; Lipman J
    Crit Care Med; 2013 Feb; 41(2):489-95. PubMed ID: 23263583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosing of piperacillin/tazobactam in a morbidly obese patient.
    Deman H; Verhaegen J; Willems L; Spriet I
    J Antimicrob Chemother; 2012 Mar; 67(3):782-3. PubMed ID: 22129593
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimicrobial dosing considerations in obese adult patients.
    Pai MP; Bearden DT
    Pharmacotherapy; 2007 Aug; 27(8):1081-91. PubMed ID: 17655508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of obesity on drug pharmacokinetics in humans.
    Morrish GA; Pai MP; Green B
    Expert Opin Drug Metab Toxicol; 2011 Jun; 7(6):697-706. PubMed ID: 21417960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults.
    Pai MP
    Pharmacotherapy; 2012 Sep; 32(9):856-68. PubMed ID: 22711238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing.
    Kendrick JG; Carr RR; Ensom MH
    Clin Ther; 2015 Sep; 37(9):1897-923. PubMed ID: 26361823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.